| scholarly article | Q13442814 |
| review article | Q7318358 |
| P6179 | Dimensions Publication ID | 1052462190 |
| P356 | DOI | 10.1186/AR2412 |
| P932 | PMC publication ID | 2582813 |
| P698 | PubMed publication ID | 19007421 |
| P5875 | ResearchGate publication ID | 23471807 |
| P50 | author | Andrew P Cope | Q61091985 |
| P2860 | cites work | Identification of substrates of human protein-tyrosine phosphatase PTPN22 | Q24303819 |
| Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4 | Q24538382 | ||
| Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies | Q24564876 | ||
| Aging, autoimmunity and arthritis: T-cell senescence and contraction of T-cell repertoire diversity - catalysts of autoimmunity and chronic inflammation | Q24797866 | ||
| CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease | Q24805444 | ||
| The molecular mechanism of osteoclastogenesis in rheumatoid arthritis | Q24806322 | ||
| Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis | Q28183279 | ||
| Medium- and large-vessel vasculitis | Q28196695 | ||
| Localization of MHC class II/human cartilage glycoprotein-39 complexes in synovia of rheumatoid arthritis patients using complex-specific monoclonal antibodies | Q28205489 | ||
| Role of PTPN22 in type 1 diabetes and other autoimmune diseases | Q28239964 | ||
| Association of a programmed death 1 gene polymorphism with the development of rheumatoid arthritis, but not systemic lupus erythematosus | Q28250589 | ||
| A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis | Q28267921 | ||
| Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant | Q28280659 | ||
| Cytokines in the pathogenesis of rheumatoid arthritis | Q28303865 | ||
| The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis | Q28306666 | ||
| MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction | Q28581447 | ||
| IL-17 family cytokines and the expanding diversity of effector T cell lineages | Q29619361 | ||
| Molecular interactions between T cells and fibroblast-like synoviocytes: role of membrane tumor necrosis factor-alpha on cytokine-activated T cells | Q30480303 | ||
| Induction of arthritis in HLA-DR4-humanized and HLA-DQ8-humanized mice by human cartilage proteoglycan aggrecan but only in the presence of an appropriate (non-MHC) genetic background. | Q31076623 | ||
| Effector function of resting T cells: activation of synovial fibroblasts | Q31838874 | ||
| Differentiation of B cells in the nonlymphoid tissue of the synovial membrane of patients with rheumatoid arthritis | Q33611035 | ||
| Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis | Q33908167 | ||
| Ectopic lymphoid organogenesis: a fast track for autoimmunity | Q34363840 | ||
| Autoantibodies to citrullinated antigens in (early) rheumatoid arthritis | Q34582303 | ||
| The role of human T-lymphocyte-monocyte contact in inflammation and tissue destruction | Q34731185 | ||
| Immunity to citrullinated proteins in rheumatoid arthritis | Q34732863 | ||
| T cell homeostasis in patients with rheumatoid arthritis | Q35200330 | ||
| Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis | Q35234747 | ||
| Proinflammatory mediator–induced reversal of CD4+,CD25+ regulatory T cell–mediated suppression in rheumatoid arthritis | Q61651901 | ||
| Defective TCR-mediated signaling in synovial T cells in rheumatoid arthritis | Q63406972 | ||
| Oligoclonality of V beta 3 TCR chains in the CD8+ T cell population of rheumatoid arthritis patients | Q70844259 | ||
| An immunohistological analysis of lymphocyte subpopulations and their microenvironment in the synovial membranes of patients with rheumatoid arthritis using monoclonal antibodies | Q71444318 | ||
| Rheumatoid synovium is enriched in mature antigen-presenting dendritic cells | Q71614430 | ||
| Shift toward T lymphocytes with a T helper 1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis | Q71878450 | ||
| Analysis of clonal CD8+ T cell expansions in normal individuals and patients with rheumatoid arthritis | Q72646584 | ||
| Expanded CD4+ and CD8+ T cell clones in elderly humans | Q73287604 | ||
| Human cartilage glycoprotein-39 as a candidate autoantigen in rheumatoid arthritis | Q73414197 | ||
| T lymphocytes in the synovial fluid of patients with active rheumatoid arthritis display CD134-OX40 surface antigen | Q74021914 | ||
| Lymphoid neogenesis in rheumatoid synovitis | Q74147962 | ||
| Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium | Q77738643 | ||
| Selective recruitment of CXCR3+ and CCR5+ CCR4+ T cells into synovial tissue in patients with rheumatoid arthritis | Q79895080 | ||
| IL-17RA and IL-17RC receptors are essential for IL-17A-induced ELR+ CXC chemokine expression in synoviocytes and are overexpressed in rheumatoid blood | Q80242052 | ||
| Antibody response to the human stress protein BiP in rheumatoid arthritis | Q80337666 | ||
| Inflammation and ectopic lymphoid structures in rheumatoid arthritis synovial tissues dissected by genomics technology: identification of the interleukin-7 signaling pathway in tissues with lymphoid neogenesis | Q80706974 | ||
| Synovial fluid leukocyte apoptosis is inhibited in patients with very early rheumatoid arthritis | Q35605600 | ||
| TNF downmodulates the function of human CD4+CD25hi T-regulatory cells | Q35849817 | ||
| TCRzetadim lymphocytes define populations of circulating effector cells that migrate to inflamed tissues | Q35924790 | ||
| Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007 | Q36171750 | ||
| CD8 T cells are required for the formation of ectopic germinal centers in rheumatoid synovitis | Q36370272 | ||
| The repertoire of CD4+ CD28- T cells in rheumatoid arthritis | Q36437991 | ||
| Cells of the synovium in rheumatoid arthritis. Synovial fibroblasts | Q36465510 | ||
| Human regulatory T cells and their role in autoimmune disease | Q36563532 | ||
| Perturbation of the T cell repertoire in rheumatoid arthritis | Q36735976 | ||
| Foxp3 in control of the regulatory T cell lineage | Q36794299 | ||
| Stress, heat shock proteins, and autoimmunity: how immune responses to heat shock proteins are to be used for the control of chronic inflammatory diseases | Q36856283 | ||
| Interleukin-17 in fashion, at last: ten years after its description, its cellular source has been identified | Q36864379 | ||
| STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus | Q37070948 | ||
| Premature telomeric loss in rheumatoid arthritis is genetically determined and involves both myeloid and lymphoid cell lineages. | Q37089409 | ||
| The role of CD8+ CD40L+ T cells in the formation of germinal centers in rheumatoid synovitis. | Q39481039 | ||
| Inhibition of T cell apoptosis in the rheumatoid synovium | Q39777667 | ||
| Stimulatory killer Ig-like receptors modulate T cell activation through DAP12-dependent and DAP12-independent mechanisms | Q40517777 | ||
| HLA-DRB1*0404 is strongly associated with anticalpastatin antibodies in rheumatoid arthritis | Q40679842 | ||
| Direct contact between T lymphocytes and monocytes is a major pathway for induction of metalloproteinase expression | Q41443072 | ||
| T-cell contact-dependent regulation of CC and CXC chemokine production in monocytes through differential involvement of NFkappaB: implications for rheumatoid arthritis | Q41815638 | ||
| Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta | Q42096868 | ||
| Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes | Q42628689 | ||
| Association of the IL4R single-nucleotide polymorphism I50V with rapidly erosive rheumatoid arthritis. | Q42684265 | ||
| T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis. | Q42767257 | ||
| Antigen-independent activation of naive and memory resting T cells by a cytokine combination | Q42942555 | ||
| Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule | Q44504170 | ||
| Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins | Q44687984 | ||
| Genetic variation in PTPN22 corresponds to altered function of T and B lymphocytes | Q44932416 | ||
| Th1 but not Th17 cells predominate in the joints of patients with rheumatoid arthritis | Q46862865 | ||
| Direct contact between T lymphocytes and human dermal fibroblasts or synoviocytes down-regulates types I and III collagen production via cell-associated cytokines. | Q47828730 | ||
| Dysregulated lymphocyte proliferation and differentiation in patients with rheumatoid arthritis. | Q52009888 | ||
| Synovial autoreactive T cells in rheumatoid arthritis resist IDO-mediated inhibition. | Q54570858 | ||
| Killer Cell Activating Receptors Function as Costimulatory Molecules on CD4+CD28null T Cells Clonally Expanded in Rheumatoid Arthritis | Q56607491 | ||
| CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid | Q56903335 | ||
| Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-α production in rheumatoid arthritis | Q57232110 | ||
| Where FoxP3-dependent regulatory T cells impinge on the development of inflammatory arthritis | Q58228376 | ||
| Differences in synovial tissue infiltrates between anti–cyclic citrullinated peptide–positive rheumatoid arthritis and anti–cyclic citrullinated peptide–negative rheumatoid arthritis | Q58234928 | ||
| Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells | Q58234949 | ||
| Immunisation against heterologous type II collagen induces arthritis in mice | Q59053172 | ||
| Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice | Q59069058 | ||
| P921 | main subject | cell | Q7868 |
| rheumatoid arthritis | Q187255 | ||
| hemic and immune systems | Q70202933 | ||
| P304 | page(s) | S1 | |
| P577 | publication date | 2008-10-15 | |
| P1433 | published in | Arthritis Research and Therapy | Q15757229 |
| P1476 | title | T cells in rheumatoid arthritis. | |
| P478 | volume | 10 Suppl 1 |
| Q36815454 | A chronic model of arthritis supported by a strain-specific periarticular lymph node in BALB/c mice |
| Q86926195 | A network pharmacology study of Sendeng-4, a Mongolian medicine |
| Q36084979 | A profile of immune response to herpesvirus is associated with radiographic joint damage in rheumatoid arthritis. |
| Q33577355 | Antigen-presenting effects of effector memory Vγ9Vδ2 T cells in rheumatoid arthritis |
| Q35629308 | Arthritogenic self-reactive CD4+ T cells acquire an FR4hiCD73hi anergic state in the presence of Foxp3+ regulatory T cells |
| Q37550704 | Aryl hydrocarbon receptor antagonism attenuates growth factor expression, proliferation, and migration in fibroblast-like synoviocytes from patients with rheumatoid arthritis |
| Q36195284 | Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease-modifying anti-rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta-analysis (NMA). |
| Q24240731 | Biologics for rheumatoid arthritis: an overview of Cochrane reviews |
| Q24240891 | Biologics for rheumatoid arthritis: an overview of Cochrane reviews |
| Q30234528 | Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis. |
| Q30235341 | Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis. |
| Q24185797 | Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease-modifying anti-rheumatic drugs: a systematic review and network meta-analysis |
| Q36330366 | CCR6(+) Th cell populations distinguish ACPA positive from ACPA negative rheumatoid arthritis |
| Q36751862 | Contributions of neutrophils to the adaptive immune response in autoimmune disease |
| Q37987351 | Current understanding of rheumatoid arthritis therapy |
| Q34320329 | Cytokine-dependent but acquired immunity-independent arthritis caused by DNA escaped from degradation |
| Q39154858 | DNA methylation at diagnosis is associated with response to disease-modifying drugs in early rheumatoid arthritis. |
| Q33686997 | ERK-dependent T cell receptor threshold calibration in rheumatoid arthritis |
| Q53475373 | Efficient T-cell priming and activation requires signaling through prostaglandin E2 (EP) receptors. |
| Q33867096 | Expanded CD23(+)/CD21(hi) B cells in inflamed lymph nodes are associated with the onset of inflammatory-erosive arthritis in TNF-transgenic mice and are targets of anti-CD20 therapy |
| Q50965491 | Experimental Arthritis Mouse Models Driven by Adaptive and/or Innate Inflammation. |
| Q33667747 | Features of the synovium of individuals at risk of developing rheumatoid arthritis: implications for understanding preclinical rheumatoid arthritis |
| Q40432151 | Functional and Structural Characterization of a Novel HLA-DRB1*04:01-Restricted α-Enolase T Cell Epitope in Rheumatoid Arthritis |
| Q60915595 | Gene-Based Nonparametric Testing of Interactions Using Distance Correlation Coefficient in Case-Control Association Studies |
| Q64106861 | Genetic variants differentially associated with rheumatoid arthritis and systemic lupus erythematosus reveal the disease-specific biology |
| Q34212663 | Genome-wide DNA methylation profiling in rheumatoid arthritis identifies disease-associated methylation changes that are distinct to individual T- and B-lymphocyte populations |
| Q40335127 | Genome-wide profiling in treatment-naive early rheumatoid arthritis reveals DNA methylome changes in T and B lymphocytes |
| Q42868832 | Host-derived CD4+ T cells attenuate stem cell-mediated transfer of autoimmune arthritis in lethally irradiated C57BL/6.g7 mice |
| Q34036703 | Immune aging and rheumatoid arthritis |
| Q38268484 | Immunoglobulin heavy-chain-binding protein (BiP): a stress protein that has the potential to be a novel therapy for rheumatoid arthritis |
| Q34185573 | Impaired activation-induced cell death promotes spontaneous arthritis in antigen (cartilage proteoglycan)-specific T cell receptor-transgenic mice |
| Q41068428 | In Vivo PET Imaging of the Activated Immune Environment in a Small Animal Model of Inflammatory Arthritis |
| Q42568723 | Inhibition of epidermal growth factor receptor tyrosine kinase ameliorates collagen-induced arthritis |
| Q38829766 | Interleukin-9 and T helper type 9 cells in rheumatic diseases. |
| Q37773271 | Joint injury and osteoarthritis: soluble mediators in the course and treatment of cartilage pathology |
| Q36056599 | K-RAS GTPase- and B-RAF kinase-mediated T-cell tolerance defects in rheumatoid arthritis |
| Q60918210 | KCa1.1 and Kv1.3 channels regulate the interactions between fibroblast-like synoviocytes and T lymphocytes during rheumatoid arthritis |
| Q33687116 | Linking power Doppler ultrasound to the presence of th17 cells in the rheumatoid arthritis joint |
| Q84582632 | Long-term therapeutic effects and safety of tacrolimus added to methotrexate in patients with rheumatoid arthritis |
| Q85643164 | Methotrexate inhibits osteoclastogenesis by decreasing RANKL-induced calcium influx into osteoclast progenitors |
| Q99605160 | Methrotexate Treatment Inmunomodulates Abnormal Cytokine Expression by T CD4 Lymphocytes Present in DMARD-Naïve Rheumatoid Arthritis Patients |
| Q26827745 | Mouse Models of Rheumatoid Arthritis |
| Q38379658 | Non-canonical NF-κB signaling in rheumatoid arthritis: Dr Jekyll and Mr Hyde? |
| Q57288028 | Pathogenic Role of Immune Cells in Rheumatoid Arthritis: Implications in Clinical Treatment and Biomarker Development |
| Q52680975 | Pharmacological characterisation of CR6086, a potent prostaglandin E2 receptor 4 antagonist, as a new potential disease-modifying anti-rheumatic drug. |
| Q33527426 | Phospholipase C gamma 2 is critical for development of a murine model of inflammatory arthritis by affecting actin dynamics in dendritic cells |
| Q37607081 | Rejuvenating the immune system in rheumatoid arthritis |
| Q38541414 | Remission in rheumatoid arthritis: is it all the same? |
| Q92913113 | Reporters of TCR signaling identify arthritogenic T cells in murine and human autoimmune arthritis |
| Q42113714 | Response to Treatment with TNFα Inhibitors in Rheumatoid Arthritis Is Associated with High Levels of GM-CSF and GM-CSF+ T Lymphocytes. |
| Q50531788 | Reversibility of peripheral blood leukocyte phenotypic and functional changes after exposure to and withdrawal from tofacitinib, a Janus kinase inhibitor, in healthy volunteers. |
| Q39619842 | Schistosoma japonicum cystatin attenuates murine collagen-induced arthritis |
| Q55261674 | Signal Transducer and Activator of Transcription 3 Hyperactivation Associates With Follicular Helper T Cell Differentiation and Disease Activity in Rheumatoid Arthritis. |
| Q38179171 | Temporal cytokine expression and the target organ attributes unravel novel aspects of autoimmune arthritis |
| Q92571224 | The Abnormal CD4+T Lymphocyte Subset Distribution and Vbeta Repertoire in New-onset Rheumatoid Arthritis Can Be Modulated by Methotrexate Treament |
| Q51707895 | The active metabolite of spleen tyrosine kinase inhibitor fostamatinib abrogates the CD4⁺ T cell-priming capacity of dendritic cells. |
| Q37013142 | The cellular composition of lymph nodes in the earliest phase of inflammatory arthritis |
| Q37734085 | The use of Mycobacterium tuberculosis HspX and GlcB proteins to identify latent tuberculosis in rheumatoid arthritis patients |
| Q34547266 | Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of coxsackievirus b3-induced viral myocarditis reduces myocardium inflammation |
| Q83390613 | Trichostatin differentially regulates Th1 and Th2 responses and alleviates rheumatoid arthritis in mice |
| Q37729042 | Update on the genetic risk factors for rheumatoid arthritis |
| Q45823713 | Upregulation of store-operated Ca(2+) entry in the naïve CD4(+) T cells with aberrant cytokine releasing in active rheumatoid arthritis |
| Q41091871 | pERK-dependent defective TCR-mediated activation of CD4+ T cells in end-stage renal disease patients. |
Search more.